The vaccine combines the antigenic components of its two meningococcal vaccines: Bexsero and Menveo. The action date is Feb. 14, 2025.
John Parkinson
Advertisement
Articles by John Parkinson
The CDC reports that the incidence of hepatitis A and B has declined.
Advertisement
Latest Updated Articles
- FDA Approves GSK's BLA for 5-in-1 Meningococcal Vaccine
Published: April 17th 2024 | Updated:
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Researchers Urge Payers to Encourage, not Inhibit, Biosimilar Competition
2
Challenges & Solutions behind post-acute care models with OneHome's Noel Gilliam
3
Fecal Transplants with Immunotherapy Extend Survival in Advanced Melanoma Patients
4
Veteran Employees in Health Systems More Likely To Stay, Get Promoted
5
